Legal
Terms of Use
Last updated: November 13, 2026
1. About us and these Terms
1.1 The website www.peregenius.com (the “Website”) is operated by Peregenius SCC Ltd (“Peregenius”, “we”, “us”), a private limited liability company registered in Malta under number C 86565, with registered office at Nu Bis Centre, Mosta Road, Lija LJA 9012, Malta, telephone +356 7728 9614, email info@peregenius.com.
1.2 Peregenius is a securitisation cell company under the Securitisation Act (Chapter 484 of the Laws of Malta) and the Securitisation Cell Companies Regulations. It is established as a notified (non-public) securitisation vehicle: it does not require a licence of the Malta Financial Services Authority (MFSA) and does not hold one, and it notifies the MFSA before commencing business in respect of each securitisation cell. Peregenius is not an investment firm, credit institution or investment adviser.
1.3 These Terms of Use (the “Terms”) apply to every use of the Website. By accessing or using the Website you accept these Terms. If you do not accept them, please do not use the Website.
2. Purpose of the Website
2.1 The Website provides general information about Peregenius, securitisation in Malta and the platform services offered to originators. Where it contains information about a securitisation cell or securities issued by Peregenius for the account of a cell (the “Securities”), this information is a summary only.
2.2 Information for originators and business partners does not constitute an offer of services. Services are provided only on the basis of a written agreement and the General Terms and Conditions for Originators of Peregenius.
3. No offer and no solicitation
3.1 Nothing on the Website constitutes an offer to sell, or a solicitation of an offer to buy, any Securities or other financial instruments, nor an invitation to enter into any investment activity. Nothing on the Website is a prospectus, a key information document or a basis for an investment decision.
3.2 Securities are not offered to the public and no prospectus is published. They are offered only by way of private placement, on the basis of the relevant offering documents (in particular the private placement memorandum, the terms of issue, the key information document where required and the subscription documents, together the “Offering Documents”), only to the investors eligible under them and only in the jurisdictions where this is permitted. In the event of any difference between the Website and the Offering Documents, the Offering Documents prevail.
3.3 Where the Website makes Offering Documents or related information available, this does not mean that the Securities may be offered to you. It is your responsibility to check whether you are permitted to invest.
4. No advice
4.1 Peregenius does not provide investment, legal, tax or accounting advice, and no content of the Website is advice or a recommendation. Peregenius does not assess whether an investment is suitable or appropriate for you.
4.2 Any investment decision is yours alone and should be based on the full Offering Documents, your own assessment of your financial situation, objectives and risk tolerance and, where needed, the advice of an independent professional adviser.
5. How an investment is made
5.1 Peregenius does not receive orders or investor money through the Website, and does not receive orders directly from investors.
5.2 All subscription orders are submitted through the distributor named in the Offering Documents, which receives and transmits the orders on a non-advised basis and carries out the assessments required by law and by the Offering Documents. For the cells where this applies, the distributor is Van Sterling Capital Limited, an investment firm licensed by the MFSA (licence VANS-IF-9616); it does not place the Securities and does not provide investment advice. Sub-distributors named in the Offering Documents may receive orders of professional investors only and transmit them to the distributor.
5.3 Where the Offering Documents allow retail investors, they may subscribe only through the distributor, after a suitability assessment (an admission test, not investment advice) and subject to the minimum amount and other admission conditions set out in the Offering Documents, and only after receiving the key information document.
5.4 Every investor is identified and onboarded by Peregenius through its KYC provider before a subscription is accepted. The board of directors of Peregenius decides on the acceptance of subscriptions and may reject a subscription without giving reasons. The register of the Securities is kept by the administrator named in the Offering Documents.
5.5 Subscription monies are paid only to the accounts of the relevant cell named in the Offering Documents. Peregenius will never ask you to pay money into any other account, to a private person or by crypto-asset transfer, and will never contact you unsolicited to sell you Securities. If you receive such a request in our name, do not respond and inform us at info@peregenius.com.
6. Access restrictions
6.1 The Website is not directed at, and may not be used by, persons in any jurisdiction where its publication or the offer of the Securities is not permitted, whether because of nationality, residence, place of business or any other reason.
6.2 In particular, the Securities have not been and will not be registered under the U.S. Securities Act of 1933 and may not be offered or sold in the United States or to or for the account of U.S. persons. The Website is not directed at persons in the United States, Canada, Australia or Japan.
6.3 Where the Offering Documents restrict an offer to certain types of investors (for example professional or qualified investors, or a minimum subscription amount), information on the Securities is intended only for those investors.
6.4 If you access the Website from a jurisdiction in which Peregenius has not obtained any required approval, you confirm that you do so on your own initiative and that you have not been solicited by Peregenius.
6.5 Peregenius may restrict access to parts of the Website, for example by asking you to confirm your country of residence or investor status. You must answer such questions truthfully.
7. Risk warnings
7.1 An investment in Securities involves significant risks, including the risk of losing all of the capital invested. In particular:
- the Securities are limited recourse obligations, payable only out of the assets of the relevant cell; investors have no claim against other cells or the non-cellular assets of Peregenius;
- the return and repayment depend on the performance of the underlying assets and on the ability of the originator and other obligors to meet their obligations;
- any security may prove insufficient or difficult to enforce;
- the Securities are generally not listed and may be difficult or impossible to sell before maturity;
- the Securities are not deposits and are not covered by a depositor or investor compensation scheme in respect of the issuer;
- tax treatment depends on your individual circumstances and may change.
7.2 The complete risk factors are set out in the Offering Documents and must be read before investing. Past performance and forecasts are not reliable indicators of future results. The value of an investment may go down as well as up.
8. Accuracy of information
8.1 We prepare the content of the Website with care, but we do not warrant that it is accurate, complete or up to date. Information may be changed or removed at any time without notice. Dated information is valid as at its date only, and we have no obligation to update it.
8.2 Forward-looking statements, forecasts and examples are based on assumptions that may prove wrong. Actual results may differ materially.
9. Third-party content and links
9.1 The Website may contain information provided by originators or other third parties, and links to third-party websites. We have no control over them and assume no responsibility for their content. Information provided by an originator about itself or its business is the responsibility of that originator.
9.2 You may link to the home page of the Website, provided the link is fair and lawful and does not suggest any association, approval or endorsement by Peregenius. Framing the Website or deep-linking to documents requires our prior written consent.
10. Intellectual property
10.1 The Website and its content, including texts, graphics, the name and logo of Peregenius and the design, are protected by copyright, trademark and other rights and belong to Peregenius or its licensors.
10.2 You may view, download and print content for your own personal, non-commercial information, provided you do not change it and keep all proprietary notices. Any other reproduction, distribution or use requires our prior written consent.
11. Acceptable use
11.1 You may not use the Website in a way that breaches the law or these Terms, that damages, overloads or interferes with the Website, or that attempts to gain unauthorised access to it, to other systems or to data. You may not use automated systems to extract content from the Website without our consent.
12. Liability
12.1 To the extent permitted by law, Peregenius is not liable for any loss or damage arising from the use of, or the inability to use, the Website or its content, from reliance on information on the Website, from interruptions or errors of the Website, or from viruses or other harmful components, save in the case of wilful misconduct or gross negligence on our part.
12.2 Nothing in these Terms limits liability for death or personal injury caused by negligence, for fraud, or any other liability that cannot be limited under applicable law, including mandatory rights of consumers.
12.3 We do not guarantee that the Website is available at all times or free of errors.
13. Conflicts of interest
13.1 Directors and officers of Peregenius may hold positions with service providers of Peregenius, including the administrator, the cell manager or the distributor, and may have interests in Securities or in companies referred to on the Website. Material conflicts of interest relating to Securities are disclosed in the Offering Documents. See also our Conflicts of Interest summary.
14. Data protection and cookies
14.1 We process personal data in accordance with Regulation (EU) 2016/679 (GDPR) and the Data Protection Act (Chapter 586 of the Laws of Malta). Details, including information on cookies, are set out in our Privacy Policy.
15. Complaints and contact
15.1 Questions and complaints regarding the Website or Peregenius can be sent to info@peregenius.com or to our postal address. Complaints are handled in accordance with our complaints procedure. Complaints regarding the handling of an order or an assessment should be addressed to the distributor named in the Offering Documents.
16. Changes to these Terms
16.1 We may change these Terms at any time by publishing the new version on the Website. The version published at the time of your visit applies. The date of the last update is shown at the top of these Terms.
17. Severability, governing law and jurisdiction
17.1 If any provision of these Terms is invalid or unenforceable, the remaining provisions remain in force.
17.2 These Terms and any dispute or claim arising out of or in connection with the Website, including non-contractual disputes, are governed by the laws of Malta.
17.3 The courts of Malta have exclusive jurisdiction, save that if you are a consumer you may also bring proceedings in, and may only be sued in, the courts of your country of residence, and you keep the protection of the mandatory provisions of the law of that country.
